Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized quadruple crossover comparison of insulin aspart, biphasic insulin aspart 50, biphasic insulin aspart 70, and fast-acting human insulin in type 1 diabetes
2008-007176-22Phase 3Completed
- Sponsor
- Aarhus University Hospital
- Start
- Feb 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of insulin aspart, Insulin aspart + insulin aspart protamine and human insulin in diabetes mellitus type 1 (T1D), sponsored by Aarhus University Hospital. Primary endpoint: Cmaxglu. Started Feb 2009; status: completed.
02
Drugs
insulin aspartInsulin aspart + insulin aspart protaminehuman insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2008-007176-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007176-22.